Diversified Trust Co Acquires 852 Shares of Waters Co. (NYSE:WAT)

Diversified Trust Co raised its holdings in shares of Waters Co. (NYSE:WAT) by 29.9% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 3,702 shares of the medical instruments supplier’s stock after acquiring an additional 852 shares during the period. Diversified Trust Co’s holdings in Waters were worth $668,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the stock. Robecosam AG grew its position in Waters by 57.7% during the second quarter. Robecosam AG now owns 211,525 shares of the medical instruments supplier’s stock worth $38,159,000 after buying an additional 77,352 shares in the last quarter. State of Alaska Department of Revenue grew its position in Waters by 59.8% during the second quarter. State of Alaska Department of Revenue now owns 28,898 shares of the medical instruments supplier’s stock worth $5,212,000 after buying an additional 10,817 shares in the last quarter. Fulton Bank N. A. grew its position in Waters by 5.6% during the second quarter. Fulton Bank N. A. now owns 1,784 shares of the medical instruments supplier’s stock worth $322,000 after buying an additional 95 shares in the last quarter. Royal Bank of Canada grew its position in Waters by 2.8% during the first quarter. Royal Bank of Canada now owns 212,090 shares of the medical instruments supplier’s stock worth $38,611,000 after buying an additional 5,792 shares in the last quarter. Finally, Optimal Asset Management Inc. grew its position in Waters by 159.5% during the first quarter. Optimal Asset Management Inc. now owns 29,278 shares of the medical instruments supplier’s stock worth $5,330,000 after buying an additional 17,995 shares in the last quarter. Institutional investors and hedge funds own 94.95% of the company’s stock.

Several brokerages have issued reports on WAT. UBS Group dropped their price target on Waters from $223.00 to $212.00 and set a “neutral” rating for the company in a research note on Tuesday, April 28th. Barclays dropped their price target on Waters from $186.00 to $172.00 and set an “underweight” rating for the company in a research note on Thursday, March 26th. Stifel Nicolaus lifted their price target on Waters from $176.00 to $180.00 and gave the stock a “hold” rating in a research note on Wednesday, April 29th. SVB Leerink dropped their price target on Waters from $210.00 to $195.00 and set a “market perform” rating for the company in a research note on Wednesday, April 29th. Finally, Needham & Company LLC started coverage on Waters in a research note on Tuesday, April 28th. They set a “sell” rating for the company. Five research analysts have rated the stock with a sell rating and six have given a hold rating to the company’s stock. Waters presently has an average rating of “Hold” and a consensus price target of $180.11.

WAT stock opened at $185.34 on Thursday. Waters Co. has a fifty-two week low of $154.39 and a fifty-two week high of $245.68. The business’s 50 day moving average price is $189.46 and its two-hundred day moving average price is $202.03. The company has a market capitalization of $11.47 billion, a price-to-earnings ratio of 21.50, a price-to-earnings-growth ratio of 5.76 and a beta of 0.94.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, April 28th. The medical instruments supplier reported $1.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.39 by ($0.24). Waters had a net margin of 22.77% and a return on equity of 1,937.83%. The business had revenue of $464.94 million for the quarter, compared to analysts’ expectations of $480.07 million. During the same period in the prior year, the company posted $1.60 EPS. The firm’s revenue was down 9.5% on a year-over-year basis. Research analysts forecast that Waters Co. will post 8.05 earnings per share for the current year.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Article: Determine Your Level of Risk Tolerance

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.